2.32BMarket Cap
36.84P/E TTM
Key Figures
101.340Open
102.100High
234.19KVolume
36.84P/E TTM
30.47P/E Dynamic
0.850Dividend TTM
1.02%Turnover Ratio
102.190Prev. Close
99.310Low
18.39MTurnover
52.57P/E Static
5.69P/B
0.84%Div Yield TTM
10.53%ROA
118.01052wk High
0.88Volume Ratio
44.04MNet Profit
22.85MShares
2.7501EPS TTM
0.55Beta
16.55%ROE
79.00552wk Low
2.73%Amplitude
72.72%Gross Margin
2.32BMarket Cap
-0.81Reward/Risk
1.83%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
LeMaitre Vascular Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 118.75.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
LeMaitre Vascular Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
LeMaitre Vascular Inc Highlights
StrengthsRisks
LeMaitre Vascular Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
LeMaitre Vascular Inc
LMAT
9
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
LeMaitre Vascular Inc Info
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Ticker SymbolLMAT
CompanyLeMaitre Vascular Inc
CEOLemaitre (George W)
Websitehttps://www.lemaitre.com/
Shareholders
FAQs
What is the current price of LeMaitre Vascular Inc (LMAT)?
The current price of LeMaitre Vascular Inc (LMAT) is 101.32.
What is the symbol of LeMaitre Vascular Inc?
The ticker symbol of LeMaitre Vascular Inc is LMAT.
What is the 52-week high of LeMaitre Vascular Inc?
The 52-week high of LeMaitre Vascular Inc is 118.01.
What is the 52-week low of LeMaitre Vascular Inc?
The 52-week low of LeMaitre Vascular Inc is 79.00.
What is the market capitalization of LeMaitre Vascular Inc?
The market capitalization of LeMaitre Vascular Inc is 2.31B.
Is LeMaitre Vascular Inc (LMAT) currently rated as Buy, Hold, or Sell?
According to analysts, LeMaitre Vascular Inc (LMAT) has an overall rating of Buy, with a price target of 118.75.
What is the Earnings Per Share (EPS TTM) of LeMaitre Vascular Inc (LMAT)?
The Earnings Per Share (EPS TTM) of LeMaitre Vascular Inc (LMAT) is 2.55.